Search Clinical Trials
596,361 trials
ID
Status
Phase
Title
Sponsor
NCT07739615
Effect of Soya Bean on the Female Reproductive Hormones and Menopausal SymptomsAlex Ekwueme Federal University Teaching HospitalNot Yet RecruitingNot Applicable
NCT07739615Not Yet Recruiting
Not Applicable
Effect of Soya Bean on the Female Reproductive Hormones and Menopausal SymptomsAlex Ekwueme Federal Univ...
NCT07739576
Descriptions and Practices of Family Engagement in Emergency Care SettingMayo ClinicNot Yet Recruiting
NCT07739576Not Yet Recruiting
—
Descriptions and Practices of Family Engagement in Emergency Care SettingMayo Clinic
NCT07740434
Work-Related Frustration and Higher Cardiovascular Risk Blood Pressure ProfilesDépartement de Médecine Générale de Dijon (DMG) - Université Bourgogne EuropeRecruiting
NCT07740434Recruiting
—
Work-Related Frustration and Higher Cardiovascular Risk Blood Pressure ProfilesDépartement de Médecine G...
NCT07739979
Radiological Outcome of Bony Fusion After Single Level Anterior Cervical Discectomy and Fusion Using Iliac Crest Graft vs. Polyetheretherketone Cage in Cervical SpondylosisServices Hospital, LahoreCompletedNot Applicable
NCT07739979Completed
Not Applicable
Radiological Outcome of Bony Fusion After Single Level Anterior Cervical Discect...Services Hospital, Lahore
NCT07739524
Iron Status Assessment in Geriatric ElderlyCentre Hospitalier Régional d'OrléansNot Yet Recruiting
NCT07739524Not Yet Recruiting
—
Iron Status Assessment in Geriatric ElderlyCentre Hospitalier Région...
NCT07738991
A Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of NKF-PEG, and US-Neulasta in Healthy Adult Male VolunteersNanjing King-Friend Biochemical Pharmaceutical Co., Ltd.RecruitingPhase 1
NCT07738991Recruiting
Phase 1
A Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of NKF...Nanjing King-Friend Bioch...
NCT07738679
Clinical Trial Evaluating the Efficacy and Safety of TQB3454 Tablets in Participants With Advanced Solid TumorsChia Tai Tianqing Pharmaceutical Group Co., Ltd.Not Yet RecruitingPhase 2
NCT07738679Not Yet Recruiting
Phase 2
Clinical Trial Evaluating the Efficacy and Safety of TQB3454 Tablets in Particip...Chia Tai Tianqing Pharmac...
NCT07739550
Low-Intensity Shock Wave Therapy for Refractory Overactive Bladder in WomenAl-Azhar UniversityNot Yet RecruitingNot Applicable
NCT07739550Not Yet Recruiting
Not Applicable
Low-Intensity Shock Wave Therapy for Refractory Overactive Bladder in WomenAl-Azhar University
NCT07738146
Painhunting Therapy Versus Cognitive Behavioural Therapy for Event-Related DepressionPainhunting LLPNot Yet RecruitingNot Applicable
NCT07738146Not Yet Recruiting
Not Applicable
Painhunting Therapy Versus Cognitive Behavioural Therapy for Event-Related Depre...Painhunting LLP
NCT07739628
Validation of a Deep Learning Tool for Opportunistic Osteoporosis Screening Using Routine Non-Contrast CT ScansUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyEnrolling By Invitation
NCT07739628Enrolling By Invitation
—
Validation of a Deep Learning Tool for Opportunistic Osteoporosis Screening Usin...Union Hospital, Tongji Me...
NCT07739745
Development Of An Endometrial Cancer Educational ToolM.D. Anderson Cancer CenterNot Yet RecruitingNot Applicable
NCT07739745Not Yet Recruiting
Not Applicable
Development Of An Endometrial Cancer Educational ToolM.D. Anderson Cancer Cent...
NCT07739355
Comparison of Efficacy and Safety Profile Between Moisturizers Containing a Combination of 5% Hydro-Urea, Ceramide, With MultiVesicular Emulsion Technology and Petrolatum on Dry Skin in the ElderlyDr. dr. Lili Legiawati, SpKK(K)CompletedPhase 3
NCT07739355Completed
Phase 3
Comparison of Efficacy and Safety Profile Between Moisturizers Containing a Comb...Dr. dr. Lili Legiawati, S...
NCT07738796
Development and Validation of a Risk Prediction Model for Cardiac Surgery-associated Acute Kidney Injury Based on the Gut-Kidney Axis, Incorporating Gut Microbiota and Their MetabolitesPeking Union Medical College HospitalNot Yet Recruiting
NCT07738796Not Yet Recruiting
—
Development and Validation of a Risk Prediction Model for Cardiac Surgery-associ...Peking Union Medical Coll...
NCT07738952
Safety and Efficacy Study of Sivelestat in Neuromyelitis Optica Spectrum DisorderKyushu UniversityNot Yet RecruitingPhase 1
NCT07738952Not Yet Recruiting
Phase 1
Safety and Efficacy Study of Sivelestat in Neuromyelitis Optica Spectrum Disorde...Kyushu University
NCT07739043
NeuroRise: Intrathecal CE-1 Treatment for Traumatic SCICell Therapy LLCNot Yet RecruitingEarly Phase 1
NCT07739043Not Yet Recruiting
Early Phase 1
NeuroRise: Intrathecal CE-1 Treatment for Traumatic SCICell Therapy LLC
NCT07739914
Everolimus bAsed caLcineurin inhibiTor frEe immunosuppRession oNe Year AfTer lIver transplantatiON (ALTERNATION)Hannover Medical SchoolNot Yet RecruitingPhase 3
NCT07739914Not Yet Recruiting
Phase 3
Everolimus bAsed caLcineurin inhibiTor frEe immunosuppRession oNe Year AfTer lIv...Hannover Medical School
NCT07738887
Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia With TP53 AlterationsAbbVieNot Yet RecruitingPhase 2
NCT07738887Not Yet Recruiting
Phase 2
Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic...AbbVie
NCT07739485
Paclitaxel Oral Solution in Triple Neagtive Breast Cancer Neoadjuvant Therapy: A Dose-Finding StudyLiu ShuNot Yet RecruitingPhase 1
NCT07739485Not Yet Recruiting
Phase 1
Paclitaxel Oral Solution in Triple Neagtive Breast Cancer Neoadjuvant Therapy: A...Liu Shu
NCT07739472
Mobile Application-Supported Education in Nursing StudentsMaltepe UniversityCompletedNot Applicable
NCT07739472Completed
Not Applicable
Mobile Application-Supported Education in Nursing StudentsMaltepe University
NCT07738107
ATR 1072 in Participants With PRKAG2 SyndromeAtrium TherapeuticsNot Yet RecruitingPhase 1
NCT07738107Not Yet Recruiting
Phase 1
ATR 1072 in Participants With PRKAG2 SyndromeAtrium Therapeutics
Result Breakdown
Not yet recruiting14 (70%)
Completed3 (15%)
Recruiting2 (10%)
Enrolling by invitation1 (5%)
not_applicable6 (30%)
Not Specified5 (25%)
Phase 14 (20%)
Phase 22 (10%)
Phase 32 (10%)
Early Phase 11 (5%)